McLaurin, K K
Farr, A M
Wade, S W
Diakun, D R
Stewart, D L
Article History
Received: 19 November 2015
Revised: 25 April 2016
Accepted: 28 April 2016
First Online: 4 August 2016
Competing interests
: KKM is an employee of AstraZeneca. AMF and DRD are employees of Truven Health Analytics, which received funding from MedImmune, the global biologics R&D arm of AstraZeneca, to conduct this analysis. DLS is a previous member of the Speaker’s Bureau for MedImmune. SWW is a consultant to Truven Health Analytics, which performed paid work for MedImmune.